Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4dce | 0JF | ALK tyrosine kinase receptor | 2.7.10.1 | 1.000 | |
| 4fnz | NZF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.647 | |
| 4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.590 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.550 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.547 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.546 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.545 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.535 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.533 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.529 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.528 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.527 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.525 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
| 4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.517 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.517 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.516 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.515 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.515 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.513 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.512 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.510 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.509 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.509 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.508 | |
| 2ym3 | YM3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.507 | |
| 3eta | 351 | Insulin receptor | 2.7.10.1 | 0.507 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.506 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.506 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.505 | |
| 2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.505 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.505 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.504 | |
| 2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.501 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.500 | |
| 4an9 | 2P7 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.500 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.500 | |
| 2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.499 | |
| 3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.499 | |
| 3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.499 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.499 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.499 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.499 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.499 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.497 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.497 | |
| 2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.495 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.495 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.495 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.494 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.494 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.493 | |
| 2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.493 | |
| 2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
| 4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
| 4ftl | H0K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.493 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.493 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.492 | |
| 2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.492 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.492 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.491 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.490 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.490 | |
| 4an3 | 5Y0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.489 | |
| 4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.489 | |
| 4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.489 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.488 | |
| 2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.487 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
| 4ftc | H6K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.487 | |
| 2qhn | 582 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.486 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.486 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.485 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.485 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.484 | |
| 1lhv | NOG | Sex hormone-binding globulin | / | 0.484 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
| 4bdh | WVI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.484 | |
| 4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.484 | |
| 4ftj | H8K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
| 4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.484 | |
| 4tv3 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | / | 0.484 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.484 | |
| 1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.483 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.483 | |
| 4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.483 | |
| 2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
| 2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.482 | |
| 3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.482 | |
| 4dk5 | 0KO | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.482 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
| 2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.481 | |
| 2xf0 | 4UB | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
| 2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.481 | |
| 2ym5 | YM5 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
| 1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.480 | |
| 2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.480 | |
| 2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.479 | |
| 4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.479 | |
| 3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.478 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 2wmx | ZY6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.477 | |
| 4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.477 | |
| 4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.474 | |
| 2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.474 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
| 2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
| 2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.473 | |
| 2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.473 | |
| 3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.473 | |
| 3zw3 | ZW3 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.473 | |
| 1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.472 | |
| 3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.472 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.472 | |
| 4wq4 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.472 | |
| 2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
| 3os3 | 3OS | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.471 | |
| 3v04 | V04 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.471 | |
| 4fta | H5K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 4gu9 | 4GU | Focal adhesion kinase 1 | 2.7.10.2 | 0.471 | |
| 2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
| 4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.470 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.470 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
| 2vgp | AD6 | Aurora kinase B-A | 2.7.11.1 | 0.469 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.469 | |
| 3bhy | 7CP | Death-associated protein kinase 3 | / | 0.469 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
| 4gap | FAD | Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial | 1.6.5.9 | 0.469 | |
| 4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.469 | |
| 4izy | 1J2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.469 | |
| 1agw | SU2 | Fibroblast growth factor receptor 1 | / | 0.468 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 1s9j | BBM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.468 | |
| 1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.468 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.468 | |
| 3v01 | 3V0 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.468 | |
| 3vjn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.468 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.468 | |
| 4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
| 4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
| 4h4q | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.468 | |
| 2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 2itu | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
| 2yiq | YIQ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.467 | |
| 2ym8 | YM8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.467 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.466 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.466 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.466 | |
| 2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.466 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.466 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.466 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
| 4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.466 | |
| 4ydu | ADP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.466 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.466 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.465 | |
| 2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.465 | |
| 3ac5 | KZM | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.465 | |
| 4ezk | 0SD | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.465 | |
| 4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.465 | |
| 4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
| 1oec | AA2 | Fibroblast growth factor receptor 2 | / | 0.464 | |
| 1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.464 | |
| 1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
| 3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.464 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
| 3w0a | DS5 | Vitamin D3 receptor | / | 0.463 | |
| 4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
| 4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
| 2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.462 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.462 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.462 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
| 4w9w | YDJ | BMP-2-inducible protein kinase | 2.7.11.1 | 0.462 | |
| 1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.461 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.461 | |
| 2gr1 | FAD | Ferredoxin reductase | / | 0.461 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.461 | |
| 3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
| 4wq5 | ATP | tRNA N6-adenosine threonylcarbamoyltransferase | / | 0.461 | |
| 1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.460 | |
| 2xba | 571 | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 3el8 | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.460 | |
| 3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.460 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 4bdi | HAU | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.460 | |
| 4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.460 | |
| 2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 2ym7 | YM7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 3liv | E16 | Protease | / | 0.459 | |
| 3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.459 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.458 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.458 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.458 | |
| 3cuk | FAD | D-amino-acid oxidase | 1.4.3.3 | 0.458 | |
| 3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.458 | |
| 3liq | E14 | Protease | / | 0.458 | |
| 3tu5 | ATP | Actin, alpha skeletal muscle | / | 0.458 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.458 | |
| 4gh2 | HK0 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
| 4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.458 | |
| 1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
| 3flk | NAI | Tartrate dehydrogenase/decarboxylase | 1.1.1.93 | 0.457 | |
| 3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.457 | |
| 4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
| 4fto | 3HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.457 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.457 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.456 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.456 | |
| 4a9s | RU9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.456 | |
| 4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.456 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.456 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.456 | |
| 4fyo | 0VF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.456 | |
| 4g1w | G1W | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.456 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.456 | |
| 4ite | TEY | Vitamin D3 receptor | / | 0.456 | |
| 1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 1rek | B8L | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.455 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.455 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
| 2vrx | 447 | Aurora kinase B-A | 2.7.11.1 | 0.455 | |
| 2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.455 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
| 3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.455 | |
| 3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.455 | |
| 4fjy | FJY | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
| 4k41 | ATP | Actin, alpha skeletal muscle | / | 0.455 | |
| 2aqu | DR7 | Gag-Pol polyprotein | 3.4.23.16 | 0.454 | |
| 2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
| 3opd | HIE | Heat shock protein 83 | / | 0.454 | |
| 3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.454 | |
| 3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.454 | |
| 3wd7 | COA | Acridone synthase | / | 0.454 | |
| 1chw | HXC | Chalcone synthase 2 | 2.3.1.74 | 0.453 | |
| 1hnc | GDN | Glutathione S-transferase Mu 2 | 2.5.1.18 | 0.453 | |
| 1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.453 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.453 | |
| 2a5u | QYT | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.453 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.453 | |
| 3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.453 | |
| 3swr | SFG | DNA (cytosine-5)-methyltransferase 1 | 2.1.1.37 | 0.453 | |
| 3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4a9m | P9M | Bromodomain-containing protein 2 | / | 0.453 | |
| 4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.453 | |
| 4kuh | CAA | 3-hydroxybutyryl-CoA dehydrogenase | / | 0.453 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.453 | |
| 1hck | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 3dga | NDP | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.452 | |
| 3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.452 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.452 | |
| 3q92 | XNB | Ketohexokinase | / | 0.452 | |
| 3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
| 4jaq | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.452 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.452 | |
| 5hes | 032 | Mitogen-activated protein kinase kinase kinase 20 | 2.7.11.25 | 0.452 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.452 | |
| 1ict | T44 | Transthyretin | / | 0.451 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.451 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.451 | |
| 2b0m | 201 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.451 | |
| 2j5n | NAD | 1-pyrroline-5-carboxylate dehydrogenase | / | 0.451 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.451 | |
| 3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.451 | |
| 3krw | BA1 | Beta-adrenergic receptor kinase 1 | 2.7.11.15 | 0.451 | |
| 3q5i | ANP | Protein kinase, putative | / | 0.451 | |
| 3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.451 | |
| 3wxy | COA | Uncharacterized protein | / | 0.451 | |
| 4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.451 | |
| 4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.451 | |
| 4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 4l4c | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.451 | |
| 1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 1q8w | M77 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.450 | |
| 3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.450 | |
| 3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
| 3vvh | 4BM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.450 | |
| 4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
| 4ftq | 4HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4h0x | NAD | Iota toxin component Ia | / | 0.450 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 4njt | 017 | Protease | / | 0.450 | |
| 4u0i | 0LI | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.450 | |
| 5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.450 | |
| 1dz6 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
| 1qpe | PP2 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
| 1w2x | RCP | Acetyl-CoA carboxylase | / | 0.449 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.449 | |
| 2bhe | BRY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 2has | C3O | Vitamin D3 receptor | / | 0.449 | |
| 2jds | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.449 | |
| 2zmd | 537 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.449 | |
| 3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
| 3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.449 | |
| 3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.449 | |
| 3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.449 | |
| 3n0t | OPY | Dipeptidyl peptidase 2 | 3.4.14.2 | 0.449 | |
| 3oib | FDA | Putative acyl-CoA dehydrogenase | / | 0.449 | |
| 3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.449 | |
| 3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.449 | |
| 4hdb | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.449 | |
| 2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2qe6 | SAM | Uncharacterized protein | / | 0.448 | |
| 2y3r | TRK | TamL | / | 0.448 | |
| 3bqr | 4RB | Death-associated protein kinase 3 | / | 0.448 | |
| 3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3n8z | FLP | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.448 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.448 | |
| 4c9p | CAM | Cytochrome P450 | / | 0.448 | |
| 4cta | ATP | CinA-like protein | / | 0.448 | |
| 4f1m | ACP | Probable serine/threonine-protein kinase roco4 | 2.7.11.1 | 0.448 | |
| 4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
| 1r6g | 442 | Thyroid hormone receptor beta | / | 0.447 | |
| 1sh9 | RIT | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
| 1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.447 | |
| 2p55 | MRA | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.447 | |
| 2qnp | QN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.447 | |
| 2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.447 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
| 3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.447 | |
| 3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3sa3 | 23X | Protease | / | 0.447 | |
| 4agw | NG7 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
| 4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.447 | |
| 4gb9 | 0WR | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
| 4h4x | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.447 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.447 | |
| 1kgj | FL8 | Transthyretin | / | 0.446 | |
| 2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.446 | |
| 2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2chw | 039 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2xnn | 430 | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.446 | |
| 2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.446 | |
| 3orm | AGS | Serine/threonine protein kinase | / | 0.446 | |
| 4c9o | CAM | Cytochrome P450 | / | 0.446 | |
| 4f9m | FCM | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
| 4wlo | NAI | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.446 | |
| 6cp4 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
| 1d3g | BRE | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.445 | |
| 2cci | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.445 | |
| 2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
| 2ydk | YDK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
| 3mvh | WFE | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.445 | |
| 3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
| 3vt3 | VDX | Vitamin D3 receptor | / | 0.445 | |
| 3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 3ztx | ZTX | Aurora kinase B-A | 2.7.11.1 | 0.445 | |
| 4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
| 4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.445 | |
| 4l8u | 9AZ | Serum albumin | / | 0.445 | |
| 4o4f | ATP | Kinase | / | 0.445 | |
| 1cx2 | S58 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.444 | |
| 1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.444 | |
| 1txi | TX5 | Vitamin D3 receptor | / | 0.444 | |
| 1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.444 | |
| 2ath | 3EA | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2i0d | MUT | Protease | / | 0.444 | |
| 2i4p | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
| 2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.444 | |
| 2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.444 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.444 | |
| 3b2t | M33 | Fibroblast growth factor receptor 2 | / | 0.444 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.444 | |
| 3sp6 | IL2 | Peroxisome proliferator-activated receptor alpha | / | 0.444 | |
| 3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
| 4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.444 | |
| 4fkp | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 4h1m | 0YJ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.444 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.444 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.444 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.444 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.444 | |
| 1ie9 | VDX | Vitamin D3 receptor | / | 0.443 | |
| 1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.443 | |
| 2c1a | I5S | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.443 | |
| 2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.443 | |
| 2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3ef6 | FAD | Toluene 1,2-dioxygenase system ferredoxin--NAD(+) reductase component | 1.18.1.3 | 0.443 | |
| 3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.443 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.443 | |
| 3nnw | EDD | Mitogen-activated protein kinase 14 | / | 0.443 | |
| 3otu | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.443 | |
| 4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.443 | |
| 4iar | ERM | 5-hydroxytryptamine receptor 1B | / | 0.443 | |
| 4l98 | LRG | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.443 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.443 | |
| 5auz | GEN | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
| 1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 1wvy | STU | Death-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
| 1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 2fxe | DR7 | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.442 | |
| 2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.442 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 4djr | 0KJ | Pol polyprotein | / | 0.442 | |
| 4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
| 4g3r | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.442 | |
| 4ia3 | BIV | Vitamin D3 receptor A | / | 0.442 | |
| 4l44 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.442 | |
| 4q73 | FAD | Bifunctional protein PutA | / | 0.442 | |
| 5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
| 1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.441 | |
| 1hvs | A77 | Gag-Pol polyprotein | / | 0.441 | |
| 1nzw | NAI | Aldehyde dehydrogenase, mitochondrial | 1.2.1.3 | 0.441 | |
| 1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 2j3k | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.441 | |
| 2q5g | 1FA | Peroxisome proliferator-activated receptor delta | / | 0.441 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.441 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.441 | |
| 2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3cis | ATP | Universal stress protein Rv2623 | / | 0.441 | |
| 3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
| 3qlx | QLR | Uncharacterized protein | / | 0.441 | |
| 4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.441 | |
| 4g6h | NAI | Rotenone-insensitive NADH-ubiquinone oxidoreductase, mitochondrial | 1.6.5.9 | 0.441 | |
| 4h50 | NAP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.441 | |
| 4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 4s34 | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 1sn0 | T44 | Transthyretin | / | 0.440 | |
| 1t44 | ATP | Actin, alpha skeletal muscle | / | 0.440 | |
| 1vij | BAY | Gag-Pol polyprotein | / | 0.440 | |
| 1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.440 | |
| 2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 2ham | C33 | Vitamin D3 receptor | / | 0.440 | |
| 2nnp | ROC | Protease | / | 0.440 | |
| 2oye | IM8 | Prostaglandin G/H synthase 1 | 1.14.99.1 | 0.440 | |
| 2qnq | QN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 2vo6 | M05 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
| 2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
| 3ckt | YDP | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 3crz | FAD | Ferredoxin--NADP+ reductase | / | 0.440 | |
| 3gbk | 2PQ | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
| 3nga | 3NG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 3ule | C69 | Actin-related protein 3 | / | 0.440 | |
| 3v9v | 21L | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
| 3vrw | YS5 | Vitamin D3 receptor | / | 0.440 | |
| 4aa0 | AA0 | Mitogen-activated protein kinase 14 | / | 0.440 | |
| 4aic | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.440 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.440 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.440 | |
| 4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.440 | |
| 4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.440 | |
| 4m69 | ANP | Receptor-interacting serine/threonine-protein kinase 3 | 2.7.11.1 | 0.440 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 4x81 | MVI | Mycinamicin III 3''-O-methyltransferase | 2.1.1.237 | 0.440 | |
| 5bp9 | SAH | Putative methyltransferase protein | / | 0.440 |